Long‐Term Major Adverse Liver Outcomes and Oncological Outcomes Across Steatotic Liver Disease Subtypes Classified Using the MetALD‐ALD Prediction Index
Yuge Li, Zhenyu Huo, Haorui Liu, Baoyuan Jiang, Qian Zhang, Si Liu et al. Long‐Term Major Adverse Liver Outcomes and Oncological Outcomes Across Steatotic Liver Disease Subtypes Classified Using the MetALD‐ALD Prediction Index. // Alimentary Pharmacology and Therapeutics. – 2026. – DOI: 10.1111/apt.70967. – URL: https://onlinelibrary.wiley.com/doi/10.1111/apt.70967?af=R
Yuge Li, Zhenyu Huo, Haorui Liu, Baoyuan Jiang, Qian Zhang, Si Liu, & Shanshan Wu (2026). Long‐Term Major Adverse Liver Outcomes and Oncological Outcomes Across Steatotic Liver Disease Subtypes Classified Using the MetALD‐ALD Prediction Index. Alimentary Pharmacology and Therapeutics. https://doi.org/10.1111/apt.70967
Yuge Li, et al. “Long‐Term Major Adverse Liver Outcomes and Oncological Outcomes Across Steatotic Liver Disease Subtypes Classified Using the MetALD‐ALD Prediction Index.” Alimentary Pharmacology and Therapeutics, 2026. doi:10.1111/apt.70967.
@article{Li2026,
title = {Long‐Term Major Adverse Liver Outcomes and Oncological Outcomes Across Steatotic Liver Disease Subtypes Classified Using the MetALD‐ALD Prediction Index},
author = {Li, Yuge and Huo, Zhenyu and Liu, Haorui and Jiang, Baoyuan and Zhang, Qian and Liu, Si and Wu, Shanshan},
journal = {Alimentary Pharmacology and Therapeutics},
year = {2026},
doi = {10.1111/apt.70967},
url = {https://onlinelibrary.wiley.com/doi/10.1111/apt.70967?af=R}
}